Prevalence and Etiologies of Intracranial Stenosis in Patients With Antiphospholipid Syndrome (ICAS_APS)
Prevalence and Etiologies of Intracranial Stenosis in Patients With Antiphospholipid Syndrome: a Cross Sectional Study (ICAS_APS)
Sponsor: Chinese University of Hong Kong
Listed as NCT05583305, this observational or N/A phase trial focuses on Antiphospholipid Syndrome and Intracranial Stenosis and remains ongoing. Sponsored by Chinese University of Hong Kong, it has been updated 6 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Aug 2025 — Present [monthly]
Enrolling By Invitation
-
Sep 2024 — Aug 2025 [monthly]
Enrolling By Invitation
-
Jul 2024 — Sep 2024 [monthly]
Enrolling By Invitation
-
Jun 2024 — Jul 2024 [monthly]
Enrolling By Invitation
-
Mar 2023 — Jun 2024 [monthly]
Enrolling By Invitation
Status: Not Yet Recruiting → Enrolling By Invitation
▶ Show 1 earlier version
-
Nov 2022 — Mar 2023 [monthly]
Not Yet Recruiting
First recorded
Oct 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Chinese University of Hong Kong
For direct contact, visit the study record on ClinicalTrials.gov .